FDA Commissioner Marty Makary Resigns Amid Agency Challenges

Makary's resignation could signal deeper issues within the FDA, potentially affecting its ability to effectively manage public health crises. The appointment of an acting commissioner may lead to a period of instability, which could hinder the agency's decision-making processes. Stakeholders will be watching closely to see how this transition impacts ongoing regulatory efforts.